windfall tax

windfall tax

windfall tax

windfall tax

windfall tax

windfall tax

07-May-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 1,388,200 shares on 04-May-2021.

take profit

sell on news qr

07-May-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 1,388,200 shares on 04-May-2021.

Post removed.Why?

windfall tax

07 May | 07:45am
UK to offer under-40s alternative to AstraZeneca Covid vaccine

07 May | 07:45am
UK to offer under-40s alternative to AstraZeneca Covid vaccine

07 May | 07:45am
UK to offer under-40s alternative to AstraZeneca Covid vaccine

MIDF Research analyst Ng Bei Shan,
who also opined that Supermax’s 9MFY21
results missed expectations, believes the
group’s ASPs were likely to have peaked
in the third quarter ended March 31, 2021
(3QFY21).
“Gauging Supermax’s latest set of re-
sults, we think that ASPs for the company
had likely peaked in 3QFY21,” she said.
She expects that ASPs may moderate
depending on the development of the pan-
demic, and how well and soon the situation
can be contained.
“We understand that some buyers are
adopting a wait-and-see approach in re-
plenishing their inventories given the high
prices currently,” she said.
She revised down her FY21 and FY22
earnings forecasts by 4.7% and 6.7% re-
spectively for Supermax as she adjusted her
ASP and input cost assumptions to better
reflect current market dynamics. While re-
iterating her “buy” call on Supermax, she
slashed TP to RM6.73 from RM13.83

06-May-2021 Additional Listing Exercise of Warrants - 1,140,500 shares at 0.500.

06-May-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 1,071,300 shares on 03-May-2021.

sell

sell

sell

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?

sell

Meanwhile, Affin Hwang Capital’s analyst Ng Chi Hoong said, Supermax 9MFY21 results missed his expectation, mainly because he has underestimated the duration of the production halt in February, which is estimated to be around 5% to 10% of the production volume for the quarter.

“We are lowering our earnings forecast for FY21 by 7% to factor in the 3QFY21 performance and lowering our TP to RM7.40 (from RM10.90),

Meanwhile, Affin Hwang Capital’s analyst Ng Chi Hoong said, Supermax 9MFY21 results missed his expectation, mainly because he has underestimated the duration of the production halt in February, which is estimated to be around 5% to 10% of the production volume for the quarter.

“We are lowering our earnings forecast for FY21 by 7% to factor in the 3QFY21 performance and lowering our TP to RM7.40 (from RM10.90),

Meanwhile, Affin Hwang Capital’s analyst Ng Chi Hoong said, Supermax 9MFY21 results missed his expectation, mainly because he has underestimated the duration of the production halt in February, which is estimated to be around 5% to 10% of the production volume for the quarter.

“We are lowering our earnings forecast for FY21 by 7% to factor in the 3QFY21 performance and lowering our TP to RM7.40 (from RM10.90),

MIDF Research’s analyst Ng Bei Shan, who also opined that Supermax’s 9MFY21 results missed expectations, believed the group’s ASPs likely to have peaked in 3QFY21.

“Gauging from Supermax’s latest set of results, we think that ASP for the company has likely peaked in 3QFY21,” she said.

She expects that ASPs may moderate depending on the development of the pandemic and how well and soon the situation can be contained.

“We understand that some buyers are adopting a wait-and-see approach in replenishing their inventories given the high prices currently,” she said.

She revised down Supermax FY21 and FY22 earnings by 4.7% and 6.7% as she adjusted her ASP and input cost assumptions to better reflect current market dynamics.

While reiterating buy call on Supermax, she lowered its TP to RM6.73 from RM13.83.

MIDF Research’s analyst Ng Bei Shan, who also opined that Supermax’s 9MFY21 results missed expectations, believed the group’s ASPs likely to have peaked in 3QFY21.

“Gauging from Supermax’s latest set of results, we think that ASP for the company has likely peaked in 3QFY21,” she said.

She expects that ASPs may moderate depending on the development of the pandemic and how well and soon the situation can be contained.

“We understand that some buyers are adopting a wait-and-see approach in replenishing their inventories given the high prices currently,” she said.

She revised down Supermax FY21 and FY22 earnings by 4.7% and 6.7% as she adjusted her ASP and input cost assumptions to better reflect current market dynamics.

While reiterating buy call on Supermax, she lowered its TP to RM6.73 from RM13.83.

MIDF Research’s analyst Ng Bei Shan, who also opined that Supermax’s 9MFY21 results missed expectations, believed the group’s ASPs likely to have peaked in 3QFY21.

“Gauging from Supermax’s latest set of results, we think that ASP for the company has likely peaked in 3QFY21,” she said.

She expects that ASPs may moderate depending on the development of the pandemic and how well and soon the situation can be contained.

“We understand that some buyers are adopting a wait-and-see approach in replenishing their inventories given the high prices currently,” she said.

She revised down Supermax FY21 and FY22 earnings by 4.7% and 6.7% as she adjusted her ASP and input cost assumptions to better reflect current market dynamics.

While reiterating buy call on Supermax, she lowered its TP to RM6.73 from RM13.83.

MIDF Research’s analyst Ng Bei Shan, who also opined that Supermax’s 9MFY21 results missed expectations, believed the group’s ASPs likely to have peaked in 3QFY21.

“Gauging from Supermax’s latest set of results, we think that ASP for the company has likely peaked in 3QFY21,” she said.

She expects that ASPs may moderate depending on the development of the pandemic and how well and soon the situation can be contained.

“We understand that some buyers are adopting a wait-and-see approach in replenishing their inventories given the high prices currently,” she said.

She revised down Supermax FY21 and FY22 earnings by 4.7% and 6.7% as she adjusted her ASP and input cost assumptions to better reflect current market dynamics.

While reiterating buy call on Supermax, she lowered its TP to RM6.73 from RM13.83.

RHB Research Institute’s analyst Alan Lim also said Supermax’s core net profit for 9MFY21 of RM2.85 billion was below expectation as it made up only 66% of his estimates.

He attributed the negative variance to the temporary closure at its production plant after the detection of several COVID-19 cases among its foreign workers.

“We have lowered FY21 to FY23 core earnings by 21% to 41% due to a lower utilisation rate assumption of 85% from 90%,” he said.

According to him, Supermax’s FY21 utilisation rate was affected by the temporary plant closure, and for FY22 to FY23, the lower utilisation rate will be due to normalised demand-supply assumptions.

He has also reduced ASP assumptions for FY21 to US$77 (from US$89), for FY22 to US$49 (from US$57), and for FY23 to US$37 (from US$48) after taking into account the recent ASP decline.

While maintaining buy call on the stock, Lim lowered Supermax’s TP to RM6.60 from RM8.75, due to the reduction in earnings estimates and long-term blended ASP to US$37.00.

RHB Research Institute’s analyst Alan Lim also said Supermax’s core net profit for 9MFY21 of RM2.85 billion was below expectation as it made up only 66% of his estimates.

He attributed the negative variance to the temporary closure at its production plant after the detection of several COVID-19 cases among its foreign workers.

“We have lowered FY21 to FY23 core earnings by 21% to 41% due to a lower utilisation rate assumption of 85% from 90%,” he said.

According to him, Supermax’s FY21 utilisation rate was affected by the temporary plant closure, and for FY22 to FY23, the lower utilisation rate will be due to normalised demand-supply assumptions.

He has also reduced ASP assumptions for FY21 to US$77 (from US$89), for FY22 to US$49 (from US$57), and for FY23 to US$37 (from US$48) after taking into account the recent ASP decline.

While maintaining buy call on the stock, Lim lowered Supermax’s TP to RM6.60 from RM8.75, due to the reduction in earnings estimates and long-term blended ASP to US$37.00.

RHB Research Institute’s analyst Alan Lim also said Supermax’s core net profit for 9MFY21 of RM2.85 billion was below expectation as it made up only 66% of his estimates.

He attributed the negative variance to the temporary closure at its production plant after the detection of several COVID-19 cases among its foreign workers.

“We have lowered FY21 to FY23 core earnings by 21% to 41% due to a lower utilisation rate assumption of 85% from 90%,” he said.

According to him, Supermax’s FY21 utilisation rate was affected by the temporary plant closure, and for FY22 to FY23, the lower utilisation rate will be due to normalised demand-supply assumptions.

He has also reduced ASP assumptions for FY21 to US$77 (from US$89), for FY22 to US$49 (from US$57), and for FY23 to US$37 (from US$48) after taking into account the recent ASP decline.

While maintaining buy call on the stock, Lim lowered Supermax’s TP to RM6.60 from RM8.75, due to the reduction in earnings estimates and long-term blended ASP to US$37.00.

RHB Research Institute’s analyst Alan Lim also said Supermax’s core net profit for 9MFY21 of RM2.85 billion was below expectation as it made up only 66% of his estimates.

He attributed the negative variance to the temporary closure at its production plant after the detection of several COVID-19 cases among its foreign workers.

“We have lowered FY21 to FY23 core earnings by 21% to 41% due to a lower utilisation rate assumption of 85% from 90%,” he said.

According to him, Supermax’s FY21 utilisation rate was affected by the temporary plant closure, and for FY22 to FY23, the lower utilisation rate will be due to normalised demand-supply assumptions.

He has also reduced ASP assumptions for FY21 to US$77 (from US$89), for FY22 to US$49 (from US$57), and for FY23 to US$37 (from US$48) after taking into account the recent ASP decline.

While maintaining buy call on the stock, Lim lowered Supermax’s TP to RM6.60 from RM8.75, due to the reduction in earnings estimates and long-term blended ASP to US$37.00.

RHB Research Institute’s analyst Alan Lim also said Supermax’s core net profit for 9MFY21 of RM2.85 billion was below expectation as it made up only 66% of his estimates.

He attributed the negative variance to the temporary closure at its production plant after the detection of several COVID-19 cases among its foreign workers.

“We have lowered FY21 to FY23 core earnings by 21% to 41% due to a lower utilisation rate assumption of 85% from 90%,” he said.

According to him, Supermax’s FY21 utilisation rate was affected by the temporary plant closure, and for FY22 to FY23, the lower utilisation rate will be due to normalised demand-supply assumptions.

He has also reduced ASP assumptions for FY21 to US$77 (from US$89), for FY22 to US$49 (from US$57), and for FY23 to US$37 (from US$48) after taking into account the recent ASP decline.

While maintaining buy call on the stock, Lim lowered Supermax’s TP to RM6.60 from RM8.75, due to the reduction in earnings estimates and long-term blended ASP to US$37.00.

RHB Research Institute’s analyst Alan Lim also said Supermax’s core net profit for 9MFY21 of RM2.85 billion was below expectation as it made up only 66% of his estimates.

He attributed the negative variance to the temporary closure at its production plant after the detection of several COVID-19 cases among its foreign workers.

“We have lowered FY21 to FY23 core earnings by 21% to 41% due to a lower utilisation rate assumption of 85% from 90%,” he said.

According to him, Supermax’s FY21 utilisation rate was affected by the temporary plant closure, and for FY22 to FY23, the lower utilisation rate will be due to normalised demand-supply assumptions.

He has also reduced ASP assumptions for FY21 to US$77 (from US$89), for FY22 to US$49 (from US$57), and for FY23 to US$37 (from US$48) after taking into account the recent ASP decline.

While maintaining buy call on the stock, Lim lowered Supermax’s TP to RM6.60 from RM8.75, due to the reduction in earnings estimates and long-term blended ASP to US$37.00.

supermax:
Following the roll-out of Covid-19 vaccines which is likely to cause glove demand to moderate, the group highlighted that global glove prices had since dropped by 15% to 25%. However, the group does not expect glove ASPs to drop sharply due to the structural change in glove consumption from new customer segments. Our TP is downgraded from RM7.80 to RM6.80 based on 11x CY22E revised EPS of 61.9 sen. Reiterate OP..

supermax:
Following the roll-out of Covid-19 vaccines which is likely to cause glove demand to moderate, the group highlighted that global glove prices had since dropped by 15% to 25%. However, the group does not expect glove ASPs to drop sharply due to the structural change in glove consumption from new customer segments. Our TP is downgraded from RM7.80 to RM6.80 based on 11x CY22E revised EPS of 61.9 sen. Reiterate OP..

supermax:
Following the roll-out of Covid-19 vaccines which is likely to cause glove demand to moderate, the group highlighted that global glove prices had since dropped by 15% to 25%. However, the group does not expect glove ASPs to drop sharply due to the structural change in glove consumption from new customer segments. Our TP is downgraded from RM7.80 to RM6.80 based on 11x CY22E revised EPS of 61.9 sen. Reiterate OP..

supermax:
Following the roll-out of Covid-19 vaccines which is likely to cause glove demand to moderate, the group highlighted that global glove prices had since dropped by 15% to 25%. However, the group does not expect glove ASPs to drop sharply due to the structural change in glove consumption from new customer segments. Our TP is downgraded from RM7.80 to RM6.80 based on 11x CY22E revised EPS of 61.9 sen. Reiterate OP..

supermax:
Following the roll-out of Covid-19 vaccines which is likely to cause glove demand to moderate, the group highlighted that global glove prices had since dropped by 15% to 25%. However, the group does not expect glove ASPs to drop sharply due to the structural change in glove consumption from new customer segments. Our TP is downgraded from RM7.80 to RM6.80 based on 11x CY22E revised EPS of 61.9 sen. Reiterate OP.

supermax:
Following the roll-out of Covid-19 vaccines which is likely to cause glove demand to moderate, the group highlighted that global glove prices had since dropped by 15% to 25%. However, the group does not expect glove ASPs to drop sharply due to the structural change in glove consumption from new customer segments. Our TP is downgraded from RM7.80 to RM6.80 based on 11x CY22E revised EPS of 61.9 sen. Reiterate OP.

Following the roll-out of Covid-19 vaccines which is likely to cause glove demand to moderate, the group highlighted that global glove prices had since dropped by 15% to 25%. However, the group does not expect glove ASPs to drop sharply due to the structural change in glove consumption from new customer segments. Our TP is downgraded from RM7.80 to RM6.80 based on 11x CY22E revised EPS of 61.9 sen. Reiterate OP.

Following the roll-out of Covid-19 vaccines which is likely to cause glove demand to moderate, the group highlighted that global glove prices had since dropped by 15% to 25%. However, the group does not expect glove ASPs to drop sharply due to the structural change in glove consumption from new customer segments. Our TP is downgraded from RM7.80 to RM6.80 based on 11x CY22E revised EPS of 61.9 sen. Reiterate OP.